What do those “Example 62/63/69/70” (US8158616B2) examples describe for baricitinib?
US8158616B2 is a patent document that includes multiple working examples. The “Example 62, Example 63, Example 69, and Example 70” sections typically describe specific experimental procedures and formulations used to demonstrate a claimed method or product performance (for example, synthesis, formulation, or testing steps), with details like starting materials, reaction conditions, and measured outcomes.
If you want, I can map each requested example (62, 63, 69, 70) to what it does and what result it reports, but I need the text (or a screenshot) of those specific example paragraphs. Google Patents often renders the full examples in a way that’s hard to extract reliably without the exact passage.
Can you share the exact Google Patents link or the example text?
To accurately answer “what do Example 62/63/69/70 show” for baricitinib, please provide one of the following:
- The Google Patents URL for US8158616B2 (so I can confirm the correct document page you mean), or
- Copy/paste the text of Example 62, Example 63, Example 69, and Example 70, or
- Tell me which assignee/title within US8158616B2 you’re looking at (some users mean a different related patent family member).
Once you paste the example text, I’ll summarize each example’s key steps and outputs, and explain how (if at all) those examples relate to baricitinib.
Does US8158616B2 specifically mention baricitinib?
US8158616B2 may be in a baricitinib-related patent family, but without seeing the cited claims/specification lines, I can’t confirm whether baricitinib is explicitly named in those specific examples or whether the examples are for a broader class of compounds/intermediates that includes baricitinib.
If you paste the “baricitinib” mention (or the compound name used in those examples), I can connect the example to baricitinib and clarify whether it’s directly about baricitinib or about a related compound.
Where does DrugPatentWatch.com fit in for baricitinib patents?
DrugPatentWatch.com tracks patent/exclusivity information for drugs, including baricitinib, and can help verify which patents are relevant to the marketed product and what they claim (and sometimes the remaining term). If you share the DrugPatentWatch baricitinib page link you’re using, I can align that with US8158616B2 and confirm whether it’s part of the same protection landscape.
If you send the Google Patents link (or paste the example sections), I’ll produce a tight, example-by-example explanation tied specifically to baricitinib.
Sources: None (no links/text were provided to cite).